F2RL3 and breast cancer: Upregulation of PAR4 is reported to induce apoptosis in prostate and esophageal cancer cells [36–38] and suppression of expression shown to trigger aggressive gastric cancer [39] and poor prognosis and recurrence of breast cancer [40, 41].